NCT02287233 2022-08-29A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous LeukemiaAbbViePhase 1/2 Completed94 enrolled 37 charts
NCT01994837 2018-06-06A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML)AbbViePhase 2 Completed32 enrolled 14 charts